Caris Life Sciences Inc
(CAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||
| Net Income | 15,597 | 9,989 |
| Depreciation Amortization | 12,921 | 15,307 |
| Income taxes - deferred | 483 | 6,297 |
| Accounts receivable | -4,993 | -1,885 |
| Other Working Capital | 6,574 | 5,759 |
| Other Operating Activity | -9,471 | -6,053 |
| Operating Cash Flow | $21,111 | $29,414 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -123,005 | -113,142 |
| Sale Of Investment | 117,164 | 102,097 |
| Other Investing Activity | 3,753 | 2,817 |
| Investing Cash Flow | $-2,088 | $-8,228 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 188,890 | 82,472 |
| Debt Repayment | -16,825 | -16,825 |
| Common Stock Repurchased | -40,104 | N/A |
| Other Financing Activity | -138,337 | -84,689 |
| Financing Cash Flow | $-6,376 | $-19,042 |
| Exchange Rate Effect | 139 | -103 |
| Beginning Cash Position | 11,842 | 5,532 |
| End Cash Position | 24,628 | 7,573 |
| Net Cash Flow | $12,786 | $2,041 |
| Free Cash Flow | ||
| Operating Cash Flow | 21,111 | 29,414 |
| Capital Expenditure | -135,338 | -127,638 |
| Free Cash Flow | -114,227 | -98,224 |